FRM
MRK icon

Fox Run Management’s Merck MRK Stock Holding History

Fox Run Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
13,212
+7,628
+137% +$881K 0.27% 56
2025
Q4 		$588K Buy
+5,584
New +$524K 0.09% 422
2025
Q3 		– Sell
-16,761
Closed -$1.33M – 1119
2025
Q2 		$1.33M Buy
16,761
+8,725
+109% +$694K 0.22% 109
2025
Q1 		$721K Buy
+8,036
New +$750K 0.11% 321
2024
Q4 		– Sell
-5,894
Closed -$669K – 1062
2024
Q3 		$669K Sell
5,894
-10,275
-64% -$1.22M 0.15% 246
2024
Q2 		$2M Buy
16,169
+13,164
+438% +$1.7M 0.38% 28
2024
Q1 		$397K Sell
3,005
-2,933
-49% -$362K 0.09% 450
2023
Q4 		$647K Buy
+5,938
New +$616K 0.17% 209
2022
Q1 		– Sell
-4,770
Closed -$366K – 629
2021
Q4 		$366K Buy
+4,770
New +$380K 0.22% 163
2019
Q4 		– Sell
-2,963
Closed -$238K – 473
2019
Q3 		$238K Buy
2,963
+124
+4% +$9.94K 0.22% 239
2019
Q2 		$227K Buy
+2,839
New +$217K 0.15% 329
2019
Q1 		– Sell
-4,690
Closed -$342K – 613
2018
Q4 		$342K Sell
4,690
-3,713
-44% -$262K 0.18% 227
2018
Q3 		$569K Buy
8,403
+2,372
+39% +$151K 0.25% 133
2018
Q2 		$349K Buy
+6,031
New +$340K 0.11% 376
2017
Q2 		– Sell
-17,816
Closed -$1.08M – 749
2017
Q1 		$1.08M Buy
17,816
+5,450
+44% +$331K 0.44% 13
2016
Q4 		$695K Buy
12,366
+8,174
+195% +$478K 0.37% 40
2016
Q3 		$250K Sell
4,192
-943
-18% -$55.1K 0.15% 326
2016
Q2 		$282K Buy
+5,135
New +$273K 0.14% 316
2016
Q1 		– Sell
-9,327
Closed -$470K – 509
2015
Q4 		$470K Buy
+9,327
New +$470K 0.36% 60

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fox Run Management's MRK Position: Q1 2026 in Review

Fox Run Management increased its Merck (MRK) stake by 137% in Q1 2026, buying an estimated $881K and bringing the position to 13,212 shares worth $1.56M. The position accounts for 0.27% of the portfolio, ranked #56.

Fox Run Management first reported a position in MRK in Q4 2015 and has held it in 19 quarters since. The position peaked at $2M in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fox Run Management held 13,212 shares of Merck worth $1.56M as of Q1 2026.
  • Fox Run Management bought 7,628 Merck shares in Q1 2026, an estimated $881K.
  • Merck made up 0.27% of Fox Run Management's portfolio in Q1 2026, its #56 holding.
  • Fox Run Management first reported a position in Merck in Q4 2015 and has held it in 19 quarters since.
  • Fox Run Management's Merck position peaked at $2M in Q2 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.